X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
gavel-in-a-courtroom

Lawyers who scored verdicts of $140 million and $150 million last year in the first trials over low testosterone medications have switched lead counsel for a trial that begins on Monday.

The trial, which is expected to last two weeks, comes in a case brought by Robert Nolte, an Arizona man who took AndroGel, a prescription gel used to treat low testosterone. It’s the third trial against AbbVie Inc. and Abbott Laboratories Inc., which are among several defendants named in 6,000 lawsuits coordinated in multidistrict litigation in federal court in Chicago. But unlike the prior AbbVie trials, which alleged the drugs caused heart attacks, this month’s trial makes claims over blood clots. Also, instead of Seeger Weiss, the lead trial counsel for the plaintiffs was set to be Ronald Johnson of Schachter, Hendy & Johnson in Fort Wright, Kentucky. Joining him on the trial team are Morgan & Morgan’s Frank Petosa of Fort Lauderdale and Keith Mitnik of Orlando, and Douglas & London’s Stephanie O’Connor in New York.

This content has been archived. It is available exclusively through our partner LexisNexis®.

To view this content, please continue to Lexis Advance®.

Not a Lexis Advance® Subscriber? Subscribe Now

Why am I seeing this?

LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® customers will be able to access and use ALM's content by subscribing to the LexisNexis® services via Lexis Advance®. This includes content from the National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.

ALM's content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.

For questions call 1-877-256-2472 or contact us at customercare@alm.com

Amanda Bronstad

Amanda Bronstad is the ALM staff reporter covering class actions and mass torts nationwide. She writes the email dispatch Critical Mass. She is based in Los Angeles.

More from this author

 

Modern Visual EvidenceBook

An essential volume in a winning trial lawyer's library. Benjamin Civiletti, former U.S. Attorney General, Venable LLP Make your courtroom presentations mo...

Get More Information
 
 

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2020 ALM Media Properties, LLC. All Rights Reserved.